<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0" xml:base="http://www.fda.gov/">
<channel>
<title>Approval letter Testing</title>
<link>https://testdocumentnamewithlargedata1testdoc.netlify.app/</link>
<description/>
<language>en</language>
<item>
<title>Supplement Approval for the Drug</title>
<link>https://testdocumentnamewithlargedata1testdoc.netlify.app/docs/M4_QandAs_R3_QandAstest1M4_QandAs_R3_QandAstest1M4_QandAs_R3_QandAstest1M4_QandAs_R3_QandAstest1M4_QandAs_R3_QandAstest1M4_QandAs_R3_test1111QandAstest1M4_QandAs_R3_QandAstest1M4_QandAs_R3_QandAstest1M4_QandAs_R3_QandAstest1M4_QandAs_R3_QandA2.pdf</link>
<description>Use of Baxter MiniCap Extended Life PD Transfer Sets during peritoneal dialysis may expose patients to higher than allowable NDL-PCBAs.</description>
<pubDate>Mon, 31 Mar 2025 00:00:00 EDT</pubDate>
<link>https://testingweb001.netlify.app/docs/Doc_Sup002.pdf</link>
<link>https://testingweb001.netlify.app/docs/Doc_Sup00113.pdf</link>
<dc:creator>FDA</dc:creator>
<guid isPermaLink="true">http://www.fda.gov/medical-devices/medical-device-recalls/peritoneal-dialysis-set-correction-baxter-issues-correction-minicap-extended-life-peritoneal</guid>
</item>

</channel>
</rss>
